# The Effects of ∆-9-THC and Naloxone in Humans

> **NCT01591629** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Naloxone
- **DRUG:** Delta-9-THC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01591629
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-04
- **Primary completion:** 2012-06-01
- **Final completion:** 2012-06-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591629, "The Effects of ∆-9-THC and Naloxone in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01591629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*